Key result
Serum subfatin levels are significantly lower in NSTEMI patients versus non-cardiac chest pain controls.
Why the study?
The study investigated the association of serum subfatin concentration and acute myocardial infarction in patients with STEMI and NSTEMI.
Can serum subfatin concentration differentiate between STEMI, NSTEMI, and controls in patients with acute myocardial infarction?
Case-Control (n=115)
No
Can serum subfatin concentration differentiate between STEMI, NSTEMI, and controls in patients with acute myocardial infarction?
Serum subfatin concentration is significantly decreased in NSTEMI and shows high sensitivity but low specificity for differentiating NSTEMI from STEMI compared to troponin.
Answers are grounded in this paper and cite their sources.
Lower subfatin in NSTEMI is hypothesis-generating; leaves open diagnostic utility versus troponin for AMI differentiation.
Introduction: We investigated the association of serum subfatin concentration and acute myocardial infarction (AMI) in patients with ST-elevation myocardial infarction (STEMI) and non-STEMI (NSTEMI). Materials and methods: enzyme-linked immunosorbent assay (ELISA). Descriptive data on the patients and their comorbidities were recorded, and subfatin concentrations were analysed. Results: Subfatin concentrations were significantly different in the control, STEMI and NSTEMI groups (P = 0.002). In addition, subfatin concentrations were significantly lower in patients in the NSTEMI group than those in the control group (P < 0.001), but there was no significant difference between STEMI and the control group (P = 0.143). The receiver operating characteristic (ROC) analysis performed for differentiating the AMI and control groups found that subfatin had 64% sensitivity and 69% specificity, whereas troponin had 59% sensitivity and 95% specificity. In patients with AMI, the ROC analysis for differentiating NSTEMI from STEMI found that subfatin had 94% sensitivity and 41% specificity, while troponin had 65% sensitivity and 88% specificity. Conclusions: Subfatin concentrations were lower in patients without STEMI than in patients with STEMI. Subfatin concentration is associated with NSTEMI.
No takes yet. Share an insight, caveat, or question.
A 2022 study conducted a case-control in Acute coronary syndrome (n=115). Serum subfatin concentration vs. Non-cardiac chest pain (control) was evaluated on Serum subfatin concentration (p=<0.001). Serum subfatin concentrations were lower in patients with non-ST-elevation myocardial infarction compared to controls with non-cardiac chest pain.
Synapse has enriched 10 related papers. Consider them for comparative context: